Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Dr Reddy terminates Armis Biopharmas investigation license of DFA-02

      Dr Reddy terminates Armis Biopharma's investigation license of DFA-02

      Medical Dialogues Bureau4 Oct 2018 9:00 AM IST
      Hyderabad: Dr. Reddy’s Laboratories Ltd. has announced the termination of the license granted to Armis Biopharma, Inc. (formerly known as CHD...
      WHO prequalification for Rotavirus vaccine from India

      WHO prequalification for Rotavirus vaccine from India

      Medical Dialogues Bureau3 Oct 2018 5:04 PM IST
      ROTASIIL is an oral vaccine administered to infants in a three-dose course at 6, 10, and 14 weeks of age, at the same time as routine vaccinations....
      Sun Pharma expects normalisation of India business in Financial year-2019

      Sun Pharma expects normalisation of India business in Financial year-2019

      Medical Dialogues Bureau3 Oct 2018 10:40 AM IST
      Shanghvi said the short-term outlook for the US generics market continues to be challenging given the pricing pressures. NEW DELHI: Sun Pharma expects...
      Fortis Healthcare appoints Girish Gupta as interim CFO

      Fortis Healthcare appoints Girish Gupta as interim CFO

      Medical Dialogues Bureau3 Oct 2018 10:15 AM IST
      Interim CFO named -Fortis said its board has approved the appointment of Girish Gupta as interim Chief Financial Officer with immediate effect. He...
      Lupin inks pact to distribute Eli Lillys diabetes injection in India

      Lupin inks pact to distribute Eli Lilly's diabetes injection in India

      Medical Dialogues Bureau3 Oct 2018 10:00 AM IST
      New Delhi: Drug major Lupin has recently announced a partnership with Eli Lilly and Company (India) to distribute Eli Lilly's diabetes injection...
      Dr Reddys Labs sells rights of cloderm cream to EPI Health LLC

      Dr Reddy's Labs sells rights of cloderm cream to EPI Health LLC

      Medical Dialogues Bureau3 Oct 2018 9:20 AM IST
      New Delhi: Dr Reddy's Laboratories (DRL) has recently announced its wholly-owned subsidiary Promius Pharma has sold rights of cloderm cream and its...
      FDA approved Nuzyra updated version of decades-old Omadacycline antibiotic

      FDA approved Nuzyra updated version of decades-old Omadacycline antibiotic

      Medical Dialogues Bureau3 Oct 2018 9:00 AM IST
      Paratek's drug, also known as omadacycline, is the first in a new class of antibiotics. It's an updated version of tetracycline, a 65-year-old...
      HC extends Suspension of Oxytocin Ban till November

      HC extends Suspension of Oxytocin Ban till November

      Medical Dialogues Bureau2 Oct 2018 11:45 AM IST
      The ban on the production and sale of the Oxytocin formulation has been suspended by the Delhi High Court till November 1st, 2018.New Delhi: The Delhi...
      Mankind Pharma eyes 1 billion Dollar Turnover by 2021: Chairman RC Juneja

      Mankind Pharma eyes 1 billion Dollar Turnover by 2021: Chairman RC Juneja

      Medical Dialogues Bureau2 Oct 2018 11:43 AM IST
      New Delhi: Drugmaker Mankind Pharma is looking at achieving a turnover of USD 1 billion by 2021 from the present Rs 5,200 crore, a top company...
      Zydus Cadila gets USFDA nod for Desoximetasone cream

      Zydus Cadila gets USFDA nod for Desoximetasone cream

      Medical Dialogues Bureau2 Oct 2018 10:20 AM IST
      New Delhi: Drug firm Zydus Cadila has recently announced that received a final nod from the US health regulator to market generic Desoximetasone cream...
      Apollo Hospitals gets shareholders approval to issue Rs 5-billion NCDs

      Apollo Hospitals gets shareholders' approval to issue Rs 5-billion NCDs

      Medical Dialogues Bureau2 Oct 2018 9:20 AM IST
      New Delhi: Apollo Hospitals, India's largest hospital chain, has recently informed stock exchanges that its shareholders had approved its plan to...
      Sanofi, Regeneron skin cancer drug gets FDA nod

      Sanofi, Regeneron skin cancer drug gets FDA nod

      Medical Dialogues Bureau2 Oct 2018 9:00 AM IST
      Sanofi Genzyme, the company’s speciality care unit and Regeneron will market Libtayo jointly in the United States.Banglore: Sanofi SA has recently...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok